At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Development of Positive Psychotherapy for Smoking Cessation
In Brief
A Phase 2 clinical trial evaluating Positive Psychotherapy for smoking cessation, Nicotine polacrilex, and 2 other interventions for Smoking. Completed, enrolled 66 participants across 1 site.
Detailed Summary
The primary objective of this study is to test a manualized adaptation of positive psychotherapy (PPT) for smoking cessation (PPT-S). The investigators will conduct a preliminary randomized clinical trial (N = 80) to examine the feasibility, acceptability, and efficacy of PPT-S over 26 weeks of follow up in comparison to a standard smoking cessation treatment. Both treatments will be delivered in individual 6 sessions over 6 weeks, and will include provision of transdermal nicotine patch. The effect size estimates from this Stage 1b research will provide the foundation for a future application to conduct a large-scale, Stage II, randomized clinical trial.
Study Details
Timeline
Interventions
6 sessions of individual behavioral smoking cessation counseling that incorporates techniques from Positive Psychotherapy to increase positive affect and reduce negative affect prior to and after quitting smoking. Intervention includes 8 weeks of transdermal nicotine patch.
8 weeks of nicotine patch
Instructions in progressive muscle relaxation
Counseling on techniques to manage triggers and avoid smoking